SS
CRBU icon

Steve Schonfeld’s Caribou Biosciences CRBU Stock Holding History

Steve Schonfeld’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,969
Closed -$45.5K – 2672
2026
Q1 		$45.5K Buy
+23,969
New +$41.1K ﹤0.01% 1987
2025
Q4 		– Sell
-558,576
Closed -$1.3M – 2130
2025
Q3 		$1.3M Sell
558,576
-1,714,290
-75% -$3.24M 0.01% 1256
2025
Q2 		$2.86M Sell
2,272,866
-78,716
-3% -$77.4K 0.02% 803
2025
Q1 		$2.15M Buy
2,351,582
+238,310
+11% +$310K 0.01% 933
2024
Q4 		$3.36M Buy
2,113,272
+467,738
+28% +$941K 0.02% 625
2024
Q3 		$3.23M Buy
1,645,534
+753,678
+85% +$1.54M 0.02% 696
2024
Q2 		$1.46M Sell
891,856
-951,058
-52% -$3.04M 0.01% 1044
2024
Q1 		$9.47M Buy
+1,842,914
New +$11.4M 0.06% 395
2022
Q4 		– Sell
-15,344
Closed -$162K – 2655
2022
Q3 		$162K Buy
15,344
+3,644
+31% +$34K ﹤0.01% 2413
2022
Q2 		$64K Sell
11,700
-3,100
-21% -$23.7K ﹤0.01% 2195
2022
Q1 		$136K Buy
+14,800
New +$156K ﹤0.01% 2137
2021
Q4 		– Sell
-10,500
Closed -$251K – 2202
2021
Q3 		$251K Buy
+10,500
New +$257K ﹤0.01% 1627

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steve Schonfeld's CRBU Position: Q2 2026 in Review

Steve Schonfeld sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 23,969 shares — an estimated $45.5K sold.

Steve Schonfeld first reported a position in CRBU in Q3 2021 and held it in 12 quarters. The position peaked at $9.47M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Steve Schonfeld reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 23,969 Caribou Biosciences shares in Q2 2026, an estimated $45.5K.
  • Steve Schonfeld first reported a position in Caribou Biosciences in Q3 2021 and held it in 12 quarters.
  • Steve Schonfeld's Caribou Biosciences position peaked at $9.47M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.